Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Sep;87(17):6808-12.
doi: 10.1073/pnas.87.17.6808.

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

A S Stern  1 , F J Podlaski, J D Hulmes, Y C Pan, P M Quinn, A G Wolitzky, P C Familletti, D L Stremlo, T Truitt, R Chizzonite, et al.
Affiliations

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

A S Stern et al. Proc Natl Acad Sci U S A. 1990 Sep.

Abstract

A cytokine that can synergize with interleukin 2 to activate cytotoxic lymphocytes was purified to homogeneity. The protein, provisionally called cytotoxic lymphocyte maturation factor (CLMF), was isolated from a human B-lymphoblastoid cell line that was induced to secrete lymphokines by culture with phorbol ester and calcium ionophore. The purification method, utilizing classical and high-performance liquid chromatographic techniques, yielded protein with a specific activity of 8.5 x 10(7) units/mg in a T-cell growth factor assay. Analysis of the purified protein by sodium dodecyl sulfate/polyacrylamide gel electrophoresis demonstrated that CLMF is a 75-kDa heterodimer composed of disulfide-bonded 40-kDa and 35-kDa subunits. Determination of the N-terminal amino acid sequences of the two subunits revealed that both subunits are not related to any previously identified cytokine. Purified CLMF stimulated the proliferation of human phytohemagglutinin-activated lymphoblasts by itself and exerted additive effects when used in combination with suboptimal amounts of interleukin 2. Furthermore, the purified protein was shown to synergize with low concentrations of interleukin 2 in causing the induction of lymphokine-activated killer cells.

PubMed Disclaimer

References

    1. Cancer Res. 1987 Aug 1;47(15):3948-53 - PubMed
    1. J Exp Med. 1989 Sep 1;170(3):827-45 - PubMed
    1. Proc Soc Exp Biol Med. 1987 Dec;186(3):253-64 - PubMed
    1. Cancer Res. 1988 Feb 15;48(4):788-92 - PubMed
    1. Cell Immunol. 1988 Jan;111(1):39-54 - PubMed

MeSH terms